Avasopasem manganese (GC4419) protects against cisplatin-induced chronic kidney disease: An exploratory analysis of renal metrics from a randomized phase 2b clinical trial in head and neck cancer patients
Avasopasem 锰 (GC4419) 可预防顺铂诱发的慢性肾病:对头颈癌患者随机 2b 期临床试验的肾脏指标进行探索性分析
期刊:Redox Biology
影响因子:10.7
doi:10.1016/j.redox.2022.102599
K A Mapuskar, G Vasquez Martinez, C F Pulliam, M S Petronek, E J Steinbach, V Monga, M Furqan, J G Jetton, D P Saunders, A Pearce, S Davidson, L Pitre, N E Dunlap, R Fairbanks, C M Lee, S L Mott, K L Bodeker, Huang Cl, J M Buatti, C M Anderson, R A Beardsley, J T Holmlund, D Zepeda-Orozco, D R Spitz